Erin Quirk - Net Worth and Insider Trading

Erin Quirk Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Erin Quirk owns 1 companies in total, including Terns Pharmaceuticals Inc (TERN) .

Click here to see the complete history of Erin Quirk’s form 4 insider trades.

Insider Ownership Summary of Erin Quirk

Ticker	Comapny	Transaction Date	Type of Owner
TERN	Terns Pharmaceuticals Inc	2021-09-28	President and CMO

Erin Quirk Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Erin Quirk Ownership Network

Ownership Network List of Erin Quirk

No Data

Ownership Network Relation of Erin Quirk

Erin Quirk Owned Company Details

What does Terns Pharmaceuticals Inc do?

Who are the key executives at Terns Pharmaceuticals Inc?

Erin Quirk is the President and CMO of Terns Pharmaceuticals Inc. Other key executives at Terns Pharmaceuticals Inc include Chief Financial Officer Mark J. Vignola , director & 10 percent owner Carl L Gordon , and director & 10 percent owner Orbimed Advisors Llc .

Terns Pharmaceuticals Inc (TERN) Insider Trades Summary

Over the past 18 months, Erin Quirk made no insider transaction in Terns Pharmaceuticals Inc (TERN). Other recent insider transactions involving Terns Pharmaceuticals Inc (TERN) include a net purchase of 5,531 shares made by Mark J. Vignola , a net sale of 47,000 shares made by Jill M. Quigley , and a net purchase of 15,531 shares made by Seokho Bryan Yoon .

In summary, during the past 3 months, insiders sold 27,235 shares of Terns Pharmaceuticals Inc (TERN) in total and bought 476,190 shares, with a net purchase of 448,955 shares. During the past 18 months, 589,991 shares of Terns Pharmaceuticals Inc (TERN) were sold and 509,363 shares were bought by its insiders, resulting in a net sale of 80,628 shares.

Terns Pharmaceuticals Inc (TERN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Terns Pharmaceuticals Inc Insider Transactions

No Available Data

Erin Quirk Mailing Address

Above is the net worth, insider trading, and ownership report for Erin Quirk. You might contact Erin Quirk via mailing address: C/o Terns Pharmaceuticals, Inc., 1065 East Hillsdale Blvd., Suite 100, Foster City Ca 94404.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.